title: Therapy: Intensive glucose control in the ICU: is sugar nice?
abstract: intensive insulin therapy is extensively used to lower blood glucose concentrations in critically ill patients hospitalized within the intensive care unit. The discovery by the nice-SUgAr study investigators that tight glucose control in this setting might actually increase mortality has generated considerable discussion about the wisdom of this approach.
authors.forename: David B
authors.initials: DB
authors.lastname: Sacks
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D016638:Critical Illness / Q000401:mortality; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007328:Insulin / Q000494:pharmacology* / Q000627:therapeutic use; D007362:Intensive Care Units
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin
references.citation: JAMA. 2008 Aug 27;300(8):933-44
references.pmid: 18728267
references.citation: N Engl J Med. 2001 Nov 8;345(19):1359-67
references.pmid: 11794168
references.citation: N Engl J Med. 2008 Jun 12;358(24):2545-59
references.pmid: 18539917
references.citation: Am J Med. 1995 Jan;98(1):75-84
references.pmid: 7825623
references.citation: Diabetes Care. 2006 Aug;29(8):1955-62
references.pmid: 16873812
references.citation: N Engl J Med. 2009 Mar 26;360(13):1283-97
references.pmid: 19318384
references.citation: Diabetes Metab Res Rev. 2007 Mar;23(3):184-92
references.pmid: 17089369
references.citation: Diabetes Care. 2007 Feb;30(2):403-9
references.pmid: 17259520